All research peptides for sale are for in-vitro research only. Products are not for human consumption of any kind.

Targeting Tumour Proliferation with a Small-Molecule Inhibitor of AICAR

“Targeting Tumour Proliferation with a Small-Molecule Inhibitor of AICAR Transformylase Homodimerization”​1​

  1. 1.
    Spurr IB, Birts CN, Cuda F, Benkovic SJ, Blaydes JP, Tavassoli A. Targeting Tumour Proliferation with a Small-Molecule Inhibitor of AICAR Transformylase Homodimerization. ChemBioChem. Published online July 4, 2012:1628-1634. doi:10.1002/cbic.201200279

 

  • AICAR 50mg

    Dr. Ian B Spurr is an experienced Clinical Research Associate with a demonstrated history of working in the pharmaceuticals industry. Skilled in CRO Management, Good Clinical Practice (GCP), Clinical Research, Clinical Trials, and Clinical Monitoring. Strong research professional with a Doctor of Philosophy (PhD) focused in Organic Chemistry from University of Southampton.

    Ian B. Spurr has a BSc Chemistry from the . Dr. Ian B. Spurr currently works at the and has 3 years experience in researching Tumor Proliferation at the . One of their notable works include "Targeting Tumour Proliferation with a Small-Molecule Inhibitor of AICAR Transformylase Homodimerization". Published online 23 Jul 2012. doi:https://doi.org/10.1002/cbic.201200279 [PubMed]
    Wiley | Researchgate | Linkedin

Estimated Reading Time: < 1 min read